Skip to main content

Carruthers Wendy's Form 4 filing

Boston Scientific Corp (BSX) · filed Nov 16, 2023

Accession no.
0001225208-23-010251
Filed
Nov 16, 2023
Trade date
Nov 15, 2023
Filing delay
1 day
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $632.2K. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Carruthers WendyCIK 0001563565Officer (EVP, Human Resources)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 15, 2023Common StockMOption exerciseAcquired+3,448$16.31+$56,236.8855,243Direct
Nov 15, 2023Common StockMOption exerciseAcquired+2,960$13.08+$38,716.858,203Direct
Nov 15, 2023Common StockSSaleDisposed−11,671$54.17F2−$632,218.0746,532Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Nov 15, 2023Common StockMOption exerciseDisposed−3,448$0.00$03,450Direct
Nov 15, 2023Common StockMOption exerciseDisposed−2,960$0.00$02,959Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $53.89 to $54.41, inclusive. The reporting person undertakes to provide upon request by the U.S.Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)